Plasma concentrations of trimethylamine-N-oxide, choline and betaine in patients with moderate to advanced chronic kidney disease and their relation to cardiovascular and renal outcomes
Trimethylamine N-oxide (TMAO) is a gut bacteria mediated liver metabolite of dietary betaine, choline, and carnitine which is excreted by glomerular filtration. We studied whether TMAO is associated with cardiovascular disease (CVD) in patients with chronic kidney disease (CKD).
Source: Journal of Renal Nutrition - Category: Urology & Nephrology Authors: Rima Obeid, Husain Awwad, Gunnar Henrik Heine, Insa E. Emrich, Danilo Fliser, Adam M. Zawada, J ürgen Geisel Tags: Original Research Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Diets | Heart | Liver | Nutrition | Trimethylamine | Urology & Nephrology